Biblio

2019
Hill BSamuel, Sarnella A, D'Avino G, Zannetti A. Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer. Semin Cancer Biol. 2019.
Berkers G, van Mourik P, Vonk AM, Kruisselbrink E, Dekkers JF, de Groot KM de Winte, Arets HGM, van der Wilt REPMarck-, Dijkema JS, Vanderschuren MM, et al. Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis. Cell Rep. 2019;26(7):1701-1708.e3.
Suzuki H, Kumar SA, Shuai S, Diaz-Navarro A, Gutiérrez-Fernández A, De Antonellis P, Cavalli FMG, Juraschka K, Farooq H, Shibahara I, et al. Recurrent non-coding U1-snRNA mutations drive cryptic splicing in Shh medulloblastoma. Nature. 2019.
Boateng LA, Campbell AD, Davenport RD, Osei-Akoto A, Hugan S, Asamoah A, Schonewille H. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease. Transfusion. 2019.
Alhaddad M, Boen M, Wu DC, Goldman MP. Red Deer Umbilical Cord Lining Mesenchymal Stem Cell Extract Cream for Rejuvenation of the Face. J Drugs Dermatol. 2019;18(4):363-366.
Valent P, Sadovnik I, Eisenwort G, Herrmann H, Bauer K, Mueller N, Sperr WR, Wicklein D, Schumacher U. Redistribution, Homing and Organ-Invasion of Neoplastic Stem Cells in Myeloid Neoplasms. Semin Cancer Biol. 2019.
Hansen J, Jones DP, Harris C. The redox theory of development. Antioxid Redox Signal. 2019.
Kronenberg G, Gertz K, Uhlemann R, Kuffner MTC, Kirste I, An J, Jadavji NM, Schott BH, Scheffel T, Endres M, et al. Reduced Hippocampal Neurogenesis in Mice Deficient in Apoptosis Repressor with Caspase Recruitment Domain (ARC). Neuroscience. 2019.
Salas MQueralt, Prem S, Atenafu EG, Law ADatt, Lam W, Al-Shaibani Z, Loach D, Kim DDong Hwan, Michelis FV, Lipton JHoward, et al. Reduced Intensity Allogeneic Stem Cell Transplant with Anti-Thymocyte globulin and Post-Transplant Cyclophosphamide in Acute Myeloid Leukemia. Eur J Haematol. 2019.
Salas MQueralt, Lam W, Law ADatt, Kim DDong Hwan, Michelis FV, Loach D, Al-Shaibani Z, Lipton JHoward, Kumar R, Mattsson J, et al. Reduced Intensity Conditioning Allogeneic Transplant with Dual T-cell Depletion in Myelofibrosis. Eur J Haematol. 2019.
Schubert MF, Noah AC, Bedi A, Gumucio JP, Mendias CL. Reduced Myogenic and Increased Adipogenic Differentiation Capacity of Rotator Cuff Muscle Stem Cells. J Bone Joint Surg Am. 2019;101(3):228-238.
El-Serafi I, Remberger M, Ringdén O, Törlén J, Sundin M, Björklund A, Winiarski J, Mattsson J. Reduced risk of sinusoidal obstruction syndrome of the liver after Busulfan-Cyclophosphamide conditioning prior to allogeneic hematopoietic stem cell transplantation. Clin Transl Sci. 2019.
Gupta A, Downey M, Shanley R, Jennissen C, Miller WP, Lund TC, Orchard PJ, Smith AR. Reduced Toxicity (BuFlu) Conditioning Is Better Tolerated but Has Higher Second Transplant Rate Compared to Myeloablative Conditioning (BuCy) in Children with Inherited Metabolic Disorders. Biol Blood Marrow Transplant. 2019.
Fu H, Zhao J, Xu L, Liu K, Wang Y, Chen H, Han W, Wang J, Wang F, Huang X, et al. Reduced β2-GPI is associated with increased platelet aggregation and activation in patients with prolonged isolated thrombocytopenia after allo-HSCT. Sci China Life Sci. 2019.
Gutiérrez-Aguirre CHomero, Alvarado-Navarro DMarisol, Palomares-Leal A, Mejía-Jaramillo G, Salazar-Riojas R, De León AGómez-, Colunga-Pedraza PRocío, Sotomayor-Duque G, Jaime-Pérez JCarlos, Cantú-Rodríguez OGraciela, et al. Reduced-dose plerixafor as a mobilization strategy in autologous hematopoietic cell transplantation: a proof of concept study. Transfusion. 2019.
Sgrignoli MRogério, Silva DAlves, Nascimento FFranco, Sgrignoli DAntonelli, Nai GAlborghett, da Silva MGuimarães, de Barros MAndrade, Bittencourt MKrähembü, de Morais BPereira, Dinallo HRangel, et al. Reduction in the inflammatory markers CD4, IL-1, IL-6 and TNFα in dogs with keratoconjunctivitis sicca treated topically with mesenchymal stem cells. Stem Cell Res. 2019;39:101525.
Liang J, Huang W, Jiang L, Paul C, Li X, Wang Y. Reduction of adverse cardiac scarring facilitates pluripotent stem cell-based therapy for myocardial infarction. Stem Cells. 2019.
Karaöz E, Tepekoy F, Yilmaz I, Subaşı C, Kabatas S. Reduction of Inflammation and Enhancement of Motility after Pancreatic Islet Derived Stem Cell Transplantation Following Spinal Cord Injury. J Korean Neurosurg Soc. 2019;62(2):153-165.
Deng G, Giralt S, Chung DJ, Landau H, Siman J, Li QS, Lapen K, Mao JJ. Reduction of Opioid Use by Acupuncture in Patients Undergoing Hematopoietic Stem Cell Transplantation: Secondary Analysis of a Randomized, Sham-Controlled Trial. Pain Med. 2019.
Augustyniak J, Lenart J, Lipka G, Stepien PP, Buzanska L. Reference Gene Validation via RT-qPCR for Human iPSC-Derived Neural Stem Cells and Neural Progenitors. Mol Neurobiol. 2019.
Amatuni GS, Sciortino S, Currier RJ, Naides SJ, Church JA, Puck JM. Reference Intervals for Lymphocyte Subsets in Preterm and Term Neonates Without Immune Defects. J Allergy Clin Immunol. 2019.
Jimenez-Vergara AC, Zurita R, Jones A, Rodroguez PDiaz, Qu X, Kusima KL, Hahn MS, Munoz-Pinto DJ. Refined Assessment of the Impact of Cell Shape on Human Mesenchymal Stem Cell Differentiation in 3D Contexts. Acta Biomater. 2019.
Doorbar J, Griffin H. Refining our understanding of cervical neoplasia and its cellular origins. Papillomavirus Res. 2019.
Takakuwa T, Okuno T, Nishimoto M, Nanno S, Takeoka Y, Nakashima Y, Koh H, Nakane T, Wanibuchi H, Hino M, et al. [Refractory ascites caused by lymphatic flow disorder after stem cell transplantation for acute myeloid leukemia]. Rinsho Ketsueki. 2019;60(1):12-16.
Kronbichler A, Brezina B, Gauckler P, Quintana LF, Jayne DRW. Refractory lupus nephritis: When, why and how to treat. Autoimmun Rev. 2019.

Pages